参考文献

[1]中华医学会糖尿病学分会.中国2型糖尿病防治指南（2020年版）.中华内分泌代谢杂志，2021，37（4）：311-398.

[2] World Health Organization. Use of glycated haemoglobin（HbA1c）in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation，Diabetes Res. Clin. Pract，2011，93（3）：299-309.

[3]中国1型糖尿病诊治指南制定委员会.中国1型糖尿病诊治指南.北京：人民卫生出版社，2013.

[4] HU C，JIA W P. Diabetes in China：epidemiology andgenetic risk factors and their clinical utility in personalized medication. Diabetes，2018，67（1）：3-11.

[5] VIRK S A，DONAGHUE K C，CHO Y H，et al. Association between HbA1c variability and risk of microvascular complications in adolescents with type 1 diabetes. J Clin Endocrinol Metab，2016，101（9）：3257-3263.

[6] ZOUNGAS S，ARIMA H，GERSTEIN H C，et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes：a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol，2017，5（6）：431-437.

[7]秦成勇，王荣.内科及药物治疗学.北京：人民卫生出版社，2006：820-823. Q82GV7ABaM45p4eC0tGjCvReNloWzO2X2bbqc0/OPMgCKl+62IjMx2bi2bbstIHa